Insmed Inc. buy Morgan Stanley
Start price
30.03.26
/
50%
€133.00
Target price
30.03.27
€184.08
Performance (%)
-16.75%
Price
08:32
?
Summary
This prediction is currently active. The prediction for Insmed Inc. disappoints with a performance of -16.75%. This prediction currently runs until 30.03.27. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -3.410% | -3.410% |
| iShares Core DAX® | -0,87 % | 5,32 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % |
| iShares S&P 500 | -0,65 % | 2,07 % |
Comments by Morgan_Stanley for this prediction
In the thread Insmed Inc. diskutieren
Insmed (INSM) was upgraded by Morgan Stanley from "equal weight" to "overweight". They now have a $212.00 price target on the stock.
Ratings data for INSM provided by MarketBeat

